Noninvasive analysis of portal pressure by contrast-enhanced sonography in patients with cirrhosis

Journal of Ultrasound in Medicine

Volumn 30, Issue 2, 2011, Pages 205-211

  Zhang, Chao Xue ^a   Hu, Jing ^a   Hu, Kong Wang ^a   Zhung, Chao ^a   Wang, Ling ^a   Xu, Jian Ming ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cirrhosis; Contrast enhanced sonography; Portal hypertension; Portal pressure

Indexed keywords

BLOOD PRESSURE; CORRELATION METHODS; ULTRASONIC IMAGING; ULTRASONOGRAPHY; VIRUSES;

CIRRHOSIS; CONTRAST-ENHANCED SONOGRAPHIES; HEPATITIS B VIRUS; NONINVASIVE ANALYSIS; PATIENT POPULATION; PEARSON CORRELATION ANALYSIS; PORTAL HYPERTENSION; POTENTIAL CAPABILITY;

LIVER;

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; ECHOGRAPHY; FEMALE; HEPATIC ARTERY; HEPATITIS B; HUMAN; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER VEIN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; VIROLOGY;

ADULT; AGED; BLOOD PRESSURE DETERMINATION; CONTRAST MEDIA; FEMALE; HEPATIC ARTERY; HEPATIC VEINS; HEPATITIS B; HUMANS; LIVER CIRCULATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PORTAL PRESSURE; PORTAL VEIN; SULFUR HEXAFLUORIDE;

EID: 79251507606     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2011.30.2.205     Document Type: Article

References (23)

1. Braillon A, Cales P, Valla D, Gaudy D, Geoffroy P, Lebrec D. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 1986; 27:1204-1209.
2. Picchiotti R, Mingazzini PL, Scucchi L, et al. Correlations between sinusoidal pressure and liver morphology in cirrhosis. J Hepatol1994; 20:364-369.
3. Kumar M, Kumar A, Hissar S, et al. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver Int 2008; 28:690-698.
4. Kumar M, Sakhuja P, Kumar A, et al. Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther 2008; 27:771-779.
5. Nicolau Molina C, Fontanilla Echeveste T, Del Cura Rodríguez JL, et al. Usefulness of contrast-enhanced ultrasonography in daily clinical practice: A multicenter study in Spain [in Spanish]. Radiologia 2010; 52:144-152.
6. Chelliah R, Senior R. An update on contrast echocardiography. Minerva Cardioangiol 2009; 57:483-493.
7. Albrecht T, Blomley MJ, Cosgrove DO, et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999; 353:1579-1583.
8. Blomley MJ, Lim AK, Harvey CJ, et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: A cross sectional study. Gut 2003; 52:1188-1193.
9. Ridolfi F, Abbattista T, Marini F, et al. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig Liver Dis 2007; 39:929-935.
10. Staub F, Tournoux-Facon C, Roumy J, et al. Liver fibrosis staging with contrast-enhanced ultrasonography: Prospective multicenter study compared with METAVIR scoring. Eur Radiol 2009; 19:1991-1997.
11. Lim AK, Taylor-Robinson SD, Patel N, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005; 54:128-133.
12. Baik SM, Kim JW, Kim HS, et al. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 2006; 240:574-580.
13. Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Gatta A. Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler. Ultrasound Med Biol 2001; 27:901-907.
14. Kawanaka H, Kinjo N, Anegawa G, et al. Abnormality of the hepatic vein waveforms in cirrhotic patients with portal hypertension and its prognostic implications. J Gastroenterol Hepatol 2008; 23:e129-e136.
15. Kim MY, Baik SK, Park DH, et al. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: A prospective nonrandomized study. Liver Int 2007; 27:1103-1110.
16. Schneider M. Characteristics of SonoVue. Echocardiography 1999; 16:743-746.
17. Pedersen JF, Larsen VA, Bytzer P, Madsen LG, Hamberg O. Hepatic transit time of ultrasound contrast in biopsy characterized liver disease. Acta Radiol 2005; 46:557-560.
18. Searle J, Mendelson R, Zelesco M, et al. Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent: A pilot study. J Med Imaging Radiat Oncol 2008; 52:130-133.
19. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46:922-938. (Pubitemid 47436138)
20. Maruyama H, Ishibashi H, Takahashi M, Imazeki F, Yokosuka O. Effect of signal intensity from the accumulated microbubbles in the liver for differentiation of idiopathic portal hypertension from liver cirrhosis. Radiology 2009; 252:587-594.
21. Lin LW, Duan XJ, Wang XY, et al. Color Doppler velocity profile and contrast-enhanced ultrasonography in assessment of liver cirrhosis. Hepatobiliary Pancreat Dis Int 2008; 7:34-39.
22. Zoli M, Iervese T, Merkel C, et al. Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. J Hepatol 1993; 17:56-61.
23. Zironi G, Gaiani S, Fenyves D, Rigamonti A, Bolondi L, Barbara L. Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol 1992; 16:298-303.